Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.

Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.

<h4>Background</h4>India started its vaccination programme for Coronavirus-19 infection (COVID-19) on 16 January 2021 with CovishieldTM (Oxford/Astra Zeneca vaccine manufactured by Serum Institute of India) and Covaxin ® (Bharat Biotech, India). We designed the present study to study the...

Full description

Bibliographic Details
Main Authors:	Aashish Contractor, Shashikala Shivaprakash, Anjali Tiwari, Maninder Singh Setia, Tarang Gianchandani
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0276759

Similar Items

Myoglobinuria-induced acute kidney injury secondary to CovishieldTM vaccination
by: Rana Fatima, et al.
Published: (2022-01-01)

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
by: Sunil Kumar Raina, et al.
Published: (2021-01-01)

Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield: A literature review
by: Ayush Kumar, et al.
Published: (2022-01-01)

Comparison of in-hospital COVID-19 related outcomes between COVISHIELD and COVAXIN recipients
by: Tejas M Suri, et al.
Published: (2022-01-01)

Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians
by: Srabanti Rakshit, et al.
Published: (2023-09-01)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
by: Amit Mittal, et al.
Published: (2022-01-01)

A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin)
by: Neerja Saraswat, et al.
Published: (2023-01-01)

Profile of adverse events following COVID-19 vaccination: Insights from Covishield, Covaxin, and Corbevax beneficiaries in India
by: Shivaji B. Kashte, et al.
Published: (2023-01-01)

Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
by: Eunice Okyere, et al.
Published: (2023-06-01)

Adverse events associated with Covishield vaccination among healthcare workers in a tertiary hospital in South India
by: Dipu T Sathyapalan, et al.
Published: (2022-12-01)

Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India
by: Partha Sarathi Satpathi, et al.
Published: (2022-10-01)

Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
by: Tarun Bhatnagar, et al.
Published: (2022-09-01)

Evaluation of CoronaVac and CoviShield Vaccines on SARS-CoV-2 Infection in Healthcare Workers in Salvador, Brazil
by: Jesús Enrique Patiño Escarcina, et al.
Published: (2023-10-01)

Barriers for Antiretroviral Therapy Adherence and Viral Suppression in Members of the Key Population in Mumbai, India: Implications for Interventions
by: Shrikala Acharya, et al.
Published: (2021-01-01)

Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational studyResearch in context
by: Mangaiarkarasi S. Asokan, et al.
Published: (2024-03-01)

Factors associated with survival in adult people living with HIV/AIDS (PLHAs) in Mumbai, India (2004-2019): A retrospective cohort study
by: Shrikala Acharya, et al.
Published: (2021-01-01)

Quantitative estimation of anti-spike SARS-CoV-2 IgG antibody response after covishield vaccination in healthcare workers
by: Megha Goyal, et al.
Published: (2022-01-01)

Inactivated vaccine Covaxin/BBV152: A systematic review
by: Tousief Irshad Ahmed, et al.
Published: (2022-08-01)

Neutralising Antibodies in Healthcare Workers after Two Doses of Covishield Vaccine at Three Months and Six Months: A Single-centre Observational Study
by: J Naveena, et al.
Published: (2022-08-01)

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
by: Jeewandara, C, et al.
Published: (2021)

Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers
by: Chandima Jeewandara, et al.
Published: (2021-07-01)

Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
by: Pragya D. Yadav, et al.
Published: (2022-10-01)

A Cross-sectional Study to Assess the Incidence of Adverse Drug Reactions to the Covishield Vaccine among Healthcare Workers of a Tertiary Care Government Institute in North India
by: Kamal Kant TRIVEDI, et al.
Published: (2023-06-01)

Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
by: Narayan Prasad, et al.
Published: (2022-06-01)

Assessment of occupational hazards among dentists practicing in Mumbai
by: E Ramaswami, et al.
Published: (2020-01-01)

Erratum: Contact tracing for COVID-19 among healthcare workers of a tertiary care hospital in Mumbai
by: .
Published: (2023-01-01)

Studying public perception about covaxin vaccination: A sentiment analysis of tweets
by: Saravanan Chinnaiyan, et al.
Published: (2022-01-01)

Assessment of adverse events following first dose of COVISHIELD in healthcare workers of a tertiary care hospital in western Uttar Pradesh: A prospective observational study
by: Shivangna Singh, et al.
Published: (2022-05-01)

COVISHIELD vaccine-induced thyroiditis: a case report
by: J. Sachin, et al.
Published: (2023-12-01)

Semen characteristics of individuals before and after Covishield™ vaccination
by: Huidrom Yaiphaba Meitei, et al.
Published: (2022-09-01)

Post-vaccination symptoms of covishield vaccine among frontline workers of a tertiary care center in Pathanamthitta District
by: Sahya S Dev, et al.
Published: (2023-01-01)

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
by: Priyamadhaba Behera, et al.
Published: (2022-01-01)

Building partnership to improve migrants’ access to healthcare in Mumbai
by: Nilesh Chandrakant Gawde, et al.
Published: (2015-11-01)

Post COVID vaccination (COVAXIN™ -BB152 V) pauci-immune crescentic glomerulonephritis
by: Shyam B Bansal, et al.
Published: (2022-01-01)

A Prospective Analysis of Sustained Immunity Following Covishield Vaccination
by: P John Solomon, et al.
Published: (2024-04-01)

Durability of ChAdOx1 nCoV-19 (Covishield<sup>®</sup>) Vaccine Induced Antibody Response in Health Care Workers
by: Alka Verma, et al.
Published: (2022-12-01)

Epidemiological study of ocular morbidities in salt pan worker in Mumbai
by: Sachin Janrao Chavan1 , Pallavi Suresh Shelke2 , Jaya Madhukar Tale3 , SatishPrabhankar4
Published: (2019-04-01)

Difficulties Faced by the Healthcare Workers Wearing Personal Protective Equipments in COVID-19 Pandemic during Summers of Mumbai City
by: Swanit Hemant Deshpande, et al.
Published: (2021-08-01)

Online partner seeking and high-risk behaviour in men who have sex with men and male-to-female transgendered people in Mumbai, India: Implications for prevention strategies.
by: Shrikala Acharya, et al.
Published: (2023-01-01)

Prevalence and determinants of adverse events following ChAdOx1 nCoV-19 vaccination (COVISHIELD) – A retrospective cohort study among healthcare workers in central Karnataka, India
by: Shubha B Davalagi, et al.
Published: (2023-01-01)